so a meeting with the FDA to "show that ATC could be clinically...

so a meeting with the FDA to "show that ATC could be clinically trialled in a different way"

"a new clinical development paradigm"

We are progressing to FDA with ATC and that will help us position and partner

and the FDA proposing a much shorter path to market for hiv drugs in treatment experienced...
www.hivforum.org/storage/hivforum/documents/2010ClinicalTrials/3_2_murray_salvage studies 3.pdf

and

the meeting with the FDA is "scheduled to take place in the first quarter of calendar 2011"

so...

when is the meeting?
when will we be informed of outcomes?
will ATC get expanded access/orphan approval?
what will be needed to get ATC to market?
who will partner and for how much?